Pirfenidone in idiopathic pulmonary fibrosis: real-life experience in the referral centre of Siena:

Background:Idiopathic pulmonary fibrosis (IPF) is the most common idiopathic interstitial pneumonia and has a median survival after diagnosis of 2–5 years. Pirfenidone is the first approved antifib...